The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune Thrombocytopenia
Clinical trial NCT01667263 · COMPLETED
Trial details
- NCT number
- NCT01667263
- Sponsor
- Peking University People's Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2016-07-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.